Your browser doesn't support javascript.
loading
Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients.
Jin, Hyun Jung; Kang, Dong Yoon; Nam, Young Hee; Ye, Young Min; Koh, Young Il; Hur, Gyu Young; Kim, Sae Hoon; Yang, Min Suk; Kim, Sujeong; Jeong, Yi Yeong; Kim, Min Hye; Choi, Jeong Hee; Kang, Hye Ryun; Jo, Eun Jung; Park, Hye Kyung.
Afiliação
  • Jin HJ; Department of Internal Medicine, Medical School of Yeungnam University, Daegu, Korea.
  • Kang DY; Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea.
  • Nam YH; Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.
  • Ye YM; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
  • Koh YI; Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.
  • Hur GY; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Yang MS; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea.
  • Kim S; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Jeong YY; Department of Internal Medicine, Gyeongsang National University College of Medicine, Gyeongsang National University Hospital, Jinju, Korea.
  • Kim MH; Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
  • Choi JH; Department of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Hwaseong and Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, Korea.
  • Kang HR; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Jo EJ; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea.
  • Park HK; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea. parkhk@pusan.ac.kr.
Allergy Asthma Immunol Res ; 13(2): 245-255, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33474859
ABSTRACT

PURPOSE:

Anti-tuberculosis drugs (ATDs) can cause severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). Underlying tuberculous infection and co-administration of multiple drugs may contribute to the complexity of ATD-related SCARs. This study aimed to investigate the clinical characteristics and outcomes of ATD-related SCARs.

METHODS:

We analyzed ATD-related SCAR cases in 2010-2015, selected from a web-based Database of the Korean Registry of SCAR.

RESULTS:

Among 783, 53 patients with ATD-induced SCARs were enrolled, including 12 with SJS/TEN (22.6%) and 41 with DRESS (77.4%). When comparing the ATD and non-ATD groups, the prevalence of DRESS patients was higher in the ATD group than in the non-ATD group (77.4% vs. 45.8%, P < 0.001). Among patients with ATD-related SCARs, those with SJS/TEN were significantly older, had higher intensive care unit admissions, and had higher mortality than those with DRESS (70.5 vs. 50.0 years, P < 0.001; 41.7% vs. 6.1%, P = 0.010; and 33.3% vs. 2.5%, P = 0.003, respectively). ATDs were challenged in 14 cases. The ATD associated most often with SCAR cases was rifampin (81.8%), followed by isoniazid (66.7%), ethambutol (50.0%), pyrazinamide (33.3%). Six patients (42.9%) had hypersensitivity reactions to 2 or more drugs.

CONCLUSIONS:

DRESS was more common among the ATD-related SCAR cases. Although treatment with most ATDs carries the risk of SCAR development, the use of rifampin was most frequently involved in the occurrence of SCARs. Multiple hypersensitivity was frequently observed in ATD-related SCARs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Allergy Asthma Immunol Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Allergy Asthma Immunol Res Ano de publicação: 2021 Tipo de documento: Article